Skip to main content

Advertisement

SpringerLink
Log in

Systematical investigation of a combinative particle size reduction technology for production of resveratrol nanosuspensions

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Nanosizing is frequently used as formulation approach to increase the bioavailability of poorly water-soluble drugs. However, standard size reduction processes can be relatively time-consuming. It was found that the modification of the physical properties of a starting material by means of spray-drying can be used to improve the effectiveness of a subsequently performed high pressure homogenization. Such a process belongs to the combinative particle size reduction methods and is also referred to as H 42 process. Based on previous studies, it was hypothesized that the improved efficiency was a result of reduced crystallinity of the modified drug. The present study was conducted in order to asses this hypothesis in a systematical manner by applying design of experiment (DoE) principles. Resveratrol was selected as model compound for this study. It was processed by both standard high pressure homogenization and by a combinative particle size reduction process (the H42 process). An optimized resveratrol/surfactant ratio for the spray-dried intermediate was identified by using the response-surface methodology. The optimization led to a nanosuspension with a mean particle size of 192 nm, which is much smaller than the mean particle size of 569 nm when standard high pressure homogenization was used. Both predominately crystalline and predominately amorphous solids resulted from the spray-drying process. In contrast to the initial hypothesis, the smallest particle sizes were achieved by processing predominately crystalline intermediate with high pressure homogenization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

REFERENCES

  1. Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59(7):631–44.

    Article  CAS  PubMed  Google Scholar 

  2. Kwade A. Wet comminution in stirred media mills—research and its practical application. Powder Technol. 1999;105(1–3):14–20.

    Article  CAS  Google Scholar 

  3. Keck CM, Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62(1):3–16.

    Article  CAS  PubMed  Google Scholar 

  4. Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 2011;63(6):427–40.

    Article  CAS  PubMed  Google Scholar 

  5. Knieke C, Sommer M, Peukert W. Identifying the apparent and true grinding limit. Powder Technol. 2009;195(1):25–30.

    Article  CAS  Google Scholar 

  6. Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453(1):142–56.

    Article  PubMed  Google Scholar 

  7. Salazar J, Müller RH, Möschwitzer JP. Performance comparison of two novel combinative particle-size-reduction technologies. J Pharm Sci. 2013;102(5):1636–49.

    Article  CAS  PubMed  Google Scholar 

  8. Möschwitzer J, Müller RH. New method for the effective production of ultrafine drug nanocrystals. J Nanosci Nanotechnol. 2006;6(9–10):3145–53.

    Article  PubMed  Google Scholar 

  9. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev. 2001;48(1):27–42.

    Article  CAS  PubMed  Google Scholar 

  10. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  11. Huang Y, Luo X, You X, Xia Y, Song X, Yu L. The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability. AAPS PharmSciTech. 2013;14(3):1236–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bucher CG, Bourgund U. A fast and efficient response-surface approach for structural reliability problems. Struct Saf. 1990;7(1):57–66.

    Article  Google Scholar 

  13. Singare DS, Marella S, Gowthamrajan K, Kulkarni GT, Vooturi R, Rao PS. Optimization of formulation and process variable of nanosuspension: an industrial perspective. Int J Pharm. 2010;402(1–2):213–20.

    Article  CAS  PubMed  Google Scholar 

  14. Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377(1–2):185–98.

    Article  CAS  PubMed  Google Scholar 

  15. Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275(5297):218–20.

    Article  CAS  PubMed  Google Scholar 

  16. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release. 2012;158(2):182–93.

    Article  CAS  PubMed  Google Scholar 

  18. Kobierski S, Ofori-Kwakye K, Müller RH, Keck CM. Resveratrol nanosuspensions for dermal application—production, characterization, and physical stability. Pharmazie. 2009;64(11):741–7.

    CAS  PubMed  Google Scholar 

  19. Popova M, Szegedi A, Mavrodinova V, Tušar NN, Mihály J, Klébert S, et al. Preparation of resveratrol-loaded nanoporous silica materials with different structures. J Solid State Chem. 2014;219:37–42.

    Article  CAS  Google Scholar 

  20. Walton D, Mumford C. The morphology of spray-dried particles: the effect of process variables upon the morphology of spray-dried particles. Chem Eng Res Des. 1999;77:442–60.

    Article  CAS  Google Scholar 

  21. Salazar J, Müller RH, Möschwitzer JP. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets. Eur J Pharm Sci. 2013;49(4):565–77.

    Article  CAS  PubMed  Google Scholar 

  22. Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J Pharm Sci. 2005;94(9):1998–2012.

    Article  CAS  PubMed  Google Scholar 

  23. Stenger F, Mende S, Schwedes J, Peukert W. Nanomilling in stirred media mills. Chem Eng Sci. 2005;60:4557–65.

    Article  CAS  Google Scholar 

  24. Torrado G, Fraile S, Torrado S, Torrado S. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods. Int J Pharm. 1998;166:55–63.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

Tao Liu would like to thank China Scholarship Council (CSC) for the financial support.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Engineering, Qingdao University of Science and Technology, Qingdao, China

    Tao Liu

  2. Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Freie Universität Berlin, Berlin, Germany

    Tao Liu, Rainer H. Müller & Jan P. Möschwitzer

  3. Pharmaceutical Development, NextPharma, Berlin, Germany

    Jan P. Möschwitzer

Authors
  1. Tao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rainer H. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan P. Möschwitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan P. Möschwitzer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, T., Müller, R.H. & Möschwitzer, J.P. Systematical investigation of a combinative particle size reduction technology for production of resveratrol nanosuspensions. AAPS PharmSciTech 18, 1683–1691 (2017). https://doi.org/10.1208/s12249-016-0612-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-016-0612-1

KEY WORDS

Search

Navigation